Cargando…
In vitro chemoresponse in metachronous pairs of gyneclologic cancers
BACKGROUND: While most gynecologic cancers respond to first-line cytotoxic chemotherapy, treatment of recurrent disease is frequently associated with acquired drug resistance. In order to find an in vitro surrogate of this clinical phenomenon, a tumor chemoresponse assay was studied. METHODS/MATERIA...
Autores principales: | Dalton, Heather J, Fiorica, James, McClure, Candace K, Rocconi, Rodney P, Recio, Fernando O, Levocchio, John L, Burrell, Matthew O, Monk, Bradley J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880960/ https://www.ncbi.nlm.nih.gov/pubmed/27231560 http://dx.doi.org/10.1186/2053-6844-1-7 |
Ejemplares similares
-
Overview of a chemoresponse assay in ovarian cancer
por: Grendys, E. C., et al.
Publicado: (2014) -
Comment on: ‘Evaluation of chemoresponse assays as predictive markers'
por: Tian, C, et al.
Publicado: (2015) -
Evaluation of chemoresponse assays as predictive markers
por: Korn, E L, et al.
Publicado: (2015) -
Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis
por: Davidson, Brittany A., et al.
Publicado: (2016) -
Response to Comment on: ‘Evaluation of chemoresponse assays as predictive biomarkers'
por: Korn, E L, et al.
Publicado: (2015)